Coronavirus: First volunteers take part in UK vaccine human trial
‘I wanted to try to support the scientific process wherever I can,’ says patient Elisa Granato
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The first volunteer to receive an injection in the UK human trials for a coronavirus vaccine was a microbiologist celebrating her 32nd birthday.
Elisa Granato said she was “excited” to help researchers at the University of Oxford find a way to fight back against the disease sweeping the globe.
“Since I don’t study viruses, I felt a bit useless these days, so I felt like this is a very easy way for me to support the cause,” she said.
Ms Granato was followed by cancer researcher Edward O’Neill, who said volunteering was “the right thing to do to ensure that we can combat this disease and get over it a lot faster.”
They are just the first two of up to 1,102 participants recruited for the trial. Six more patients will follow on Saturday, with the numbers to rapidly increase from Monday.
Half of them will receive the potential Covid-19 vaccine and the others will receive a “control” vaccine for meningitis.
However, because this is a clinical trial, none of the volunteers will be told which one they have received.
Professor Sarah Gilbert, who is leading the Oxford Vaccine Group, said she is ”very optimistic” about its chances for success.
She said: “There’s absolutely no suggestion we’re going to start using this vaccine in a wider population before we’ve demonstrated that it actually works and stops getting people infected with coronavirus.”
The group hopes to have at least a million doses of its candidate vaccine ready in September.
Other participants, who are due to receive their doses next week, have revealed how the team has explained the risks involved.
“We’ve had to give explicit consent at every step of the way,” Lydia Guthrie told BBC Radio 4. ”They’re really clear with us that as participants we can pull out at any time if we change our minds.”
She said that after receiving the jab should would keep a diary about how she feels and list any potential symptoms.
Meanwhile another team at Imperial College London is developing its own vaccine and hopes to start its own clinical trials in June.
Additional reporting by Press Association
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments